Natural Beauty Bio-Technology Limited

Sembol: 0157.HK

HKSE

0.51

HKD

Bugünkü piyasa fiyatı

-67.5714
F/K Oranı
-2.4025
PEG Oranı
1.02B
MRK Kapağı
0.00%
DIV Verimi

Natural Beauty Bio-Technology Limited (0157-HK) Finansal Tablolar

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Natural Beauty Bio-Technology Limited (0157.HK). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Natural Beauty Bio-Technology Limited'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	166.8	168.6	197.1	165.6	149.1	183.9	288.9	428.6	502.7	583.3	507.4	432.4	558.7	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	304.9	141.9
balance-sheet.row.short-term-investments	8.1	8	8.9	7.5	10.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.1	65.8
balance-sheet.row.net-receivables	85.4	80.9	119.9	118.9	103.7	71.3	98.2	73	41.2	50.8	83.7	55.1	0	44.7	0	93	0	164.9	141.2	124.6	130.7	0	0
balance-sheet.row.inventory	77.6	98.8	121	103.3	85.5	74.3	85.1	49.8	46.9	45	47	67.4	40.3	46.7	89.1	100.9	71	63.6	56.5	55.7	62.7	52.7	52.7
balance-sheet.row.other-current-assets	13.3	16.3	12.1	12	21.2	18.2	19.7	14.5	18.8	17	29.3	0.3	56.2	0.4	86.1	0.4	99.2	28	26.7	94.4	67.6	101.1	64.4
balance-sheet.row.total-current-assets	343	364.6	450	399.8	359.5	347.8	491.9	565.9	609.6	696.1	667.4	555.2	655.2	667.3	734.5	740.5	759	612.7	563.2	510.6	431.3	458.8	258.9
balance-sheet.row.property-plant-equipment-net	270.6	238.4	417.1	369.6	345	197.2	198.6	173.5	187.4	223.7	257.2	285.1	261.1	232.1	217.8	230.6	218	335.7	338.4	353.4	352.5	362.2	377.7
balance-sheet.row.goodwill	25.2	25.7	29.6	28.8	27.4	31.4	27.1	25.5	27	28.3	28.4	27.6	27.5	26.6	25.8	25.8	24.6	23.2	13.9	16.8	23.6	0	0
balance-sheet.row.intangible-assets	0	25.7	35.3	42.9	42.4	17.1	27.1	25.5	27	9.1	9.5	9.5	0	0	0	0	0	0	0.9	2.1	3.2	16.5	5.5
balance-sheet.row.goodwill-and-intangible-assets	25.2	51.4	64.9	71.7	69.8	48.5	27.1	25.5	27	28.3	28.4	37.1	27.5	26.6	25.8	25.8	24.6	23.2	14.8	18.9	26.8	16.5	5.5
balance-sheet.row.long-term-investments	217.7	228.7	9.5	8.8	7.9	11.2	7.9	8.9	10.2	250	284.6	-6.3	0	0	0	0	0	7.2	7.3	7.4	12.2	-76.9	-61.3
balance-sheet.row.tax-assets	24.4	25.2	25	19	12.9	5.2	217.8	190.2	0.6	2	1	0.7	0	0	3	9.2	7.5	9.4	4.7	4.7	9.8	0.8	1
balance-sheet.row.other-non-current-assets	1.6	-24.7	-29.3	-28.1	-27	-16.4	-225.7	-199.1	-10.8	-252	-285.6	12.3	14.8	14.9	18.2	20.2	23.2	9.5	9	5.2	8.7	100.1	65.8
balance-sheet.row.total-non-current-assets	539.5	518.9	487.1	441	408.6	245.7	225.7	199.1	214.4	252	285.6	328.8	303.4	273.6	264.8	285.7	273.3	385	374.3	389.6	410.1	402.7	388.6
balance-sheet.row.other-assets	0	0	0	0	0	85.4	60.3	57.2	64.6	29.7	29.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.account-payables	20.7	9.8	15.2	26.1	26.2	20.5	21.5	20.9	14.9	18.6	21.3	18	135.8	126.1	93.8	106	90.3	70.2	82	55.5	53.7	82.8	135.2
balance-sheet.row.short-term-debt	171.7	119.4	94.8	59.5	22.1	-22.6	-6	-6.2	-6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.tax-payables	3	7.5	19.3	9.7	4.7	9.7	18.4	24.3	28	43.8	26.7	12.7	12.8	9	14.5	41.2	4.7	27.6	15.8	20.7	13.5	11.3	20.8
balance-sheet.row.long-term-debt-total	3.5	6	9.5	2.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	24.1	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	71.2	104.8	114.4	107.2	82.5	105.3	94.1	141.8	128.7	172.6	159.6	108	19.3	19.6	24.8	51.6	14.5	37	24.2	29.9	18.8	16.6	20.8
balance-sheet.row.total-non-current-liabilities	24.7	35.3	41.3	24.9	42.1	1.3	11.5	4.8	12.3	12.6	13	10.1	15.3	12.6	11.9	12.3	11.9	11.3	10.9	10.2	8.4	7.6	6.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	11.1	18	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	308.1	286.1	279.2	229.5	200.3	127.1	127.1	167.5	156	203.8	193.8	136.1	170.4	158.3	130.5	169.8	116.7	118.5	117.2	95.6	80.8	107	164.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.1	200	0	0	0	0	0	0
balance-sheet.row.retained-earnings	39.1	54.6	85.4	50.3	42.8	189.1	259	314	355.5	361.3	365	169.8	0	0	0	0	0	0	0	0	0	118.2	105.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	263.6	271.1	294.7	277.1	241.3	255.1	284.9	220.4	256.8	128.8	139.5	-129	-104.1	-96.2	-117.3	-118.7	-141.8	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	71.6	71.6	77.6	83.6	83.6	-92.6	-93.3	-79.9	-79.9	83.6	83.6	507.1	691.9	678.4	785.2	768.6	851.4	878.7	813.5	795	750.4	615.9	348.7
balance-sheet.row.total-stockholders-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748.2	788	782.5	868.1	850	909.6	878.7	813.5	795	750.4	734.1	454.3
balance-sheet.row.total-liabilities-and-stockholders-equity	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	-0.2	0.2	0.1	0.7	6.4	6	0.4	6.8	9.7	10.2	20.3	28.3
balance-sheet.row.total-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748	788.2	782.6	868.8	856.4	915.7	879.2	820.3	804.6	760.6	754.5	482.6
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	225.8	236.7	18.4	16.3	18.1	2.9	7.9	8.9	10.2	250	284.6	-6.3	0	0	3.9	5.9	9.1	7.2	7.3	7.4	12.2	11.3	4.4
balance-sheet.row.total-debt	186.3	143.5	129.1	75	52.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.net-debt	27.5	-17.1	-59.1	-83.1	-86.1	-181	-288.9	-428.6	-502.7	-583.3	-507.4	-432.4	-558.7	-575.5	-559.3	-546.2	-588.7	-356.2	-338.7	-235.9	-170.3	-216.8	-74

Nakit Akış Tablosu

Natural Beauty Bio-Technology Limited'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	155.3	173.6	75.8	186.8	308.5	208	122.8	81	62.7	54.1	66.5	71
cash-flows.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	-12.2	-29.6	43.1	-38.6	-44.4	0	-61.1	-35.3	-50.8	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	9.3	1.1	1	-28	30.2	0	0.5	0.2	0.1	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	4.4	-0.1	-35.8	-28.1	-45	19.7	-65.7	-33.1	2.8	28.5	-44.1	-55.6	-3.5	86.4	-6.5	-14.9	110.1	-42.6	-45.9	18.5	-62.3	0	0
cash-flows.row.account-receivables	1	19.7	6.7	0.3	-42.7	25	-28.4	-29.9	9.1	31.7	-58	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	16.5	-1	-27	-24.7	-17.7	-5.3	-37.3	-3.3	-6.3	-3.3	13.9	-35.9	3.7	14.9	-3.2	-27	-7.4	-8.4	-9.2	7	-22.2	0	0
cash-flows.row.account-payables	-16.1	-23.3	-16.6	12.7	10.4	-11.7	-40.9	14.7	-35.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	3	4.4	1	-16.5	5	11.7	40.9	-14.7	35.8	0	0	-19.7	-7.2	71.5	-3.4	12.1	117.6	-34.1	-36.6	11.5	-40.1	0	0
cash-flows.row.other-non-cash-items	0.3	4.6	8.4	13.2	12.5	3.6	-39.1	-9.8	-42.7	25.5	53.9	-7	-8.7	-7.9	12.9	-6.3	-10.7	4.1	50.9	43.8	18.2	-17.8	40.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.acquisitions-net	0	0.3	8.2	20.1	0	-18.9	0	0	0	0	0	0	0	0	0	-3.5	1	0	0	0	-7.2	-0.9	-0.8
cash-flows.row.purchases-of-investments	0	0	-1.3	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	-9	3.2	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	9	25	0	9.6	0.3	30.8	-31.7	13.8	9.4	10.6	10.2	9.5	12.9	36.5	165.2	-10.5	74.7	-8.9	14.9	-19.6	-11.9
cash-flows.row.net-cash-used-for-investing-activites	-69.1	-44	-31.2	-50.6	-63.7	-61.1	-32	11.7	-46.1	-4.7	-13.1	-50.6	-40.5	-27.7	-4.2	-2.4	112.4	-21.8	49.8	-23.1	-4	-66.2	-87.1
cash-flows.row.debt-repayment	-54.3	-31.2	-27.2	-38.8	-24.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.1	-0.2
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-6	-6	0	0	-96.1	-99.7	-140.5	-142.3	-74.7	-25.6	-140.2	-160.2	-150.2	-137.1	-300	-185	-80.3	-61.3	-45	-52.3	-94.2	-39.8
cash-flows.row.other-financing-activites	104	55.3	47.6	68.6	45.1	0	-60.9	-50.1	0	0	0	-0.8	0	0	0	0.4	5.1	0	0	0	0	254	9.5
cash-flows.row.net-cash-used-provided-by-financing-activities	49.6	18.1	14.3	29.9	20.2	-96.1	-160.6	-190.6	-142.3	-74.7	-25.6	-140.9	-160.2	-150.2	-137.1	-299.7	-179.9	-80.3	-61.3	-45	-52.3	157.7	-30.5
cash-flows.row.effect-of-forex-changes-on-cash	1.4	-9.9	4.1	9.7	-3	-18	31.7	-23.2	-32.3	-9.9	5.4	6.2	13.1	20.1	0.3	-9.8	25.7	13.4	2.7	0.9	-0.3	0.5	-8.1
cash-flows.row.net-change-in-cash	-1.8	-27.6	30.1	19.2	-45.5	-130.7	-139.7	-74.1	-80.6	75.9	75	-125.9	-17.2	16.1	13.1	-42.5	232.5	17.5	102.8	65.7	-46.5	140.7	-14.5
cash-flows.row.cash-at-end-of-period	158.7	160.6	188.2	158.2	139	158.2	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1
cash-flows.row.cash-at-beginning-of-period	160.6	188.2	158.2	139	184.5	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1	90.6
cash-flows.row.operating-cash-flow	16.2	8.3	42.8	30.1	20.3	74	21.2	128	140.1	165.1	108.3	59.5	170.4	173.9	154.1	269.3	274.2	106.2	111.7	132.8	10.1	48.7	111.3
cash-flows.row.capital-expenditure	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.free-cash-flow	-52.9	-36	4.7	-43.8	-56.1	22.2	-11.1	108.9	125.7	146.6	85.7	-1.7	119.6	136.7	137	233.9	220.4	94.9	86.8	118.6	-1.7	3	36.8

Gelir Tablosu Satırı

Natural Beauty Bio-Technology Limited'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 0157.HK brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	336	335.9	487.8	410.7	438.4	369.5	399.6	475.2	506.9	505.8	439.4	483.4	591.3	485.4	538.1	592.7	450.1	363.7	357.9	358.1	320.1	306.3	254.6
income-statement-row.row.cost-of-revenue	157.3	170.6	206	193.4	190.1	146.7	94.5	122.4	109.4	117	106.3	103.6	122.2	130	122.9	86.1	77.6	68.7	73.3	82.3	61.2	86.8	63.8
income-statement-row.row.gross-profit	178.7	165.3	281.8	217.2	248.3	222.9	305.1	352.9	397.5	388.8	333.1	379.8	469.1	355.4	415.2	506.6	372.6	295	284.6	275.9	258.9	219.5	190.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.operating-expenses	182.5	188.7	237	212.9	209.2	186.7	162.7	162.8	238.8	286	259.4	227.7	295.5	279.5	230.8	198.1	164.3	167.7	207.8	176.5	194.9	162.8	117.2
income-statement-row.row.cost-and-expenses	339.8	359.3	443.1	406.4	399.3	333.4	257.2	285.2	348.2	403	365.7	331.3	417.6	409.5	353.7	284.2	241.8	236.4	281.1	258.7	256.1	249.6	181
income-statement-row.row.interest-income	1.5	1.7	2.1	1.7	1.6	3	4.3	6.2	11.7	13.5	9.3	7	0	0	2.4	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.total-operating-expenses	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	-19.5	-28.4	-6.4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-3.8	-23.4	44.7	4.3	39.1	37.3	137.8	162.9	150.7	126.4	63.1	155.3	173.6	75.8	186.8	308.5	208.3	127.3	76.8	99.4	83.5	85.1	79.9
income-statement-row.row.income-before-tax	-11.9	-23.5	48.5	9	37	39.2	146.7	196.2	170.4	116.3	83.1	155.3	173.6	75.8	186.8	308.5	208	174.5	119.8	99.1	83.5	87	82.2
income-statement-row.row.income-tax-expense	3.2	6.9	13.2	1.2	15.1	12.9	41.4	47.8	33.6	44.8	24.6	36.1	58.5	45.1	42.8	69.9	29.2	51.6	38.8	36.3	30.1	21.9	12.5
income-statement-row.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	119.3	115.1	31.3	149.6	238.5	178.7	122.8	81	62.7	54.1	66.5	71